These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19833632)

  • 1. Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin.
    Ashby DR; Gale DP; Busbridge M; Murphy KG; Duncan ND; Cairns TD; Taube DH; Bloom SR; Tam FW; Chapman R; Maxwell PH; Choi P
    Haematologica; 2010 Mar; 95(3):505-8. PubMed ID: 19833632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early effects of erythropoietin on serum hepcidin and serum iron bioavailability in healthy volunteers.
    Lainé F; Laviolle B; Ropert M; Bouguen G; Morcet J; Hamon C; Massart C; Westermann M; Deugnier Y; Loréal O
    Eur J Appl Physiol; 2012 Apr; 112(4):1391-7. PubMed ID: 21818622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights.
    Rhodes CJ; Howard LS; Busbridge M; Ashby D; Kondili E; Gibbs JS; Wharton J; Wilkins MR
    J Am Coll Cardiol; 2011 Jul; 58(3):300-9. PubMed ID: 21737024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15.
    Fertrin KY; Lanaro C; Franco-Penteado CF; de Albuquerque DM; de Mello MR; Pallis FR; Bezerra MA; Hatzlhofer BL; Olbina G; Saad ST; da Silva Araújo A; Westerman M; Costa FF
    Am J Hematol; 2014 Apr; 89(4):385-90. PubMed ID: 24860871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum hepcidin levels and muscle iron proteins in humans injected with low- or high-dose erythropoietin.
    Robach P; Recalcati S; Girelli D; Campostrini N; Kempf T; Wollert KC; Corbella M; Santambrogio P; Perbellini L; Brasse-Lagnel C; Christensen B; Moutereau S; Lundby C; Cairo G
    Eur J Haematol; 2013 Jul; 91(1):74-84. PubMed ID: 23582009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of hepcidin expression at high altitude.
    Talbot NP; Lakhal S; Smith TG; Privat C; Nickol AH; Rivera-Ch M; León-Velarde F; Dorrington KL; Mole DR; Robbins PA
    Blood; 2012 Jan; 119(3):857-60. PubMed ID: 22130801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin.
    Robach P; Recalcati S; Girelli D; Gelfi C; Aachmann-Andersen NJ; Thomsen JJ; Norgaard AM; Alberghini A; Campostrini N; Castagna A; Viganò A; Santambrogio P; Kempf T; Wollert KC; Moutereau S; Lundby C; Cairo G
    Blood; 2009 Jun; 113(26):6707-15. PubMed ID: 19264680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project.
    Piperno A; Galimberti S; Mariani R; Pelucchi S; Ravasi G; Lombardi C; Bilo G; Revera M; Giuliano A; Faini A; Mainini V; Westerman M; Ganz T; Valsecchi MG; Mancia G; Parati G;
    Blood; 2011 Mar; 117(10):2953-9. PubMed ID: 21149632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin-driven signaling ameliorates the survival defect of DMT1-mutant erythroid progenitors and erythroblasts.
    Horvathova M; Kapralova K; Zidova Z; Dolezal D; Pospisilova D; Divoky V
    Haematologica; 2012 Oct; 97(10):1480-8. PubMed ID: 22580996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in iron status and hepcidin expression in rats.
    Kong WN; Niu QM; Ge L; Zhang N; Yan SF; Chen WB; Chang YZ; Zhao SE
    Biol Trace Elem Res; 2014 Aug; 160(2):258-67. PubMed ID: 24962641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cell surface transferrin receptor-2 by iron-dependent cleavage and release of a soluble form.
    Pagani A; Vieillevoye M; Nai A; Rausa M; Ladli M; Lacombe C; Mayeux P; Verdier F; Camaschella C; Silvestri L
    Haematologica; 2015 Apr; 100(4):458-65. PubMed ID: 25637053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of hepcidin during anemia requires erythropoietic activity.
    Pak M; Lopez MA; Gabayan V; Ganz T; Rivera S
    Blood; 2006 Dec; 108(12):3730-5. PubMed ID: 16882706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepcidin expression in patients with acute leukaemia.
    Cheng PP; Sun ZZ; Jiang F; Tang YT; Jiao XY
    Eur J Clin Invest; 2012 May; 42(5):517-25. PubMed ID: 22023453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepcidin expression in the liver of mice with implanted tumour reacts to iron deficiency, inflammation and erythropoietin administration.
    Vokurka M; Krijt J; Vávrová J; Nečas E
    Folia Biol (Praha); 2011; 57(6):248-54. PubMed ID: 22264719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of iron transport and the role of transferrin.
    Gkouvatsos K; Papanikolaou G; Pantopoulos K
    Biochim Biophys Acta; 2012 Mar; 1820(3):188-202. PubMed ID: 22085723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum prohepcidin is associated with soluble transferrin receptor-1 but not ferritin in healthy post-menopausal women.
    Huang X; Fung ET; Yip C; Zeleniuch-Jacquotte A
    Blood Cells Mol Dis; 2008; 41(3):265-9. PubMed ID: 18694648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating iron levels influence the regulation of hepcidin following stimulated erythropoiesis.
    Mirciov CSG; Wilkins SJ; Hung GCC; Helman SL; Anderson GJ; Frazer DM
    Haematologica; 2018 Oct; 103(10):1616-1626. PubMed ID: 29903760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepcidin is correlated to soluble hemojuvelin but not to increased GDF15 during pregnancy.
    Finkenstedt A; Widschwendter A; Brasse-Lagnel CG; Theurl I; Hubalek M; Dieplinger H; Tselepis C; Ward DG; Vogel W; Zoller H
    Blood Cells Mol Dis; 2012 Apr; 48(4):233-7. PubMed ID: 22365732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatoid anemia.
    Masson C
    Joint Bone Spine; 2011 Mar; 78(2):131-7. PubMed ID: 20851655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of testosterone on hepcidin, ferroportin, ferritin and iron binding capacity in patients with hypogonadotropic hypogonadism and type 2 diabetes.
    Dhindsa S; Ghanim H; Batra M; Kuhadiya ND; Abuaysheh S; Green K; Makdissi A; Chaudhuri A; Dandona P
    Clin Endocrinol (Oxf); 2016 Nov; 85(5):772-780. PubMed ID: 27292585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.